Infliximab in patients with primary Sjögren's syndrome: A pilot study

Arthritis and Rheumatism

Volumn 44, Issue 10, 2001, Pages 2371-2375

  Steinfeld, Serge D ^a   Demols, Paul ^b   Salmon, Isabelle ^a   Kiss, Robert ^a   Appelboom, Thierry ^b  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; DNA ANTIBODY; DOUBLE STRANDED DNA; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DYSPNEA; ERYTHEMA; FEMALE; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SJOEGREN SYNDROME;

ADULT; AGED; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; SJOGREN'S SYNDROME; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034767874     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200110)44:10<2371::AID-ART401>3.0.CO;2-W     Document Type: Article

References (20)

1. Sjögren's syndrome
2. Prevalence of Sjören's syndrome in a closed rural community
3. Current issues in the diagnosis and treatment of Sjögren's syndrome
4. Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren's syndrome
5. Cytokine and adhesion molecule expression in the minor salivary glands of patients with Sjögren's syndrome and chronic sialoadenitis
6. Differential cytokine mRNA expression in human labial minor salivary glands in primary Sjögren's syndrome
7. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome
8. Th1 predominance and perforin expression from patients with primary Sjögren's syndrome
9. Role of cytokines in the destruction of acinar structure in Sjögren's syndrome salivary glands
10. Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage
11. Cytokines in autoimmunity
12. Suppression of tumor necrosis factor α-induced matrix metalloproteinase 9 production by the introduction of a superrepressor form of inhibitor of nuclear factor κBα complementary DNA into immortalized human salivary gland acinar cells: Prevention of the destruction of the acinar structure in Sjögren's syndrome salivary glands
13. Treatment with pegylated recombinant methionyl human soluble tumor necrosis factor-type 1 receptor (PEG sTNF-R1) prevents development of Sjögren's syndrome and diabetes in the NOD mouse model
14. Current concepts on diagnosis, autoantibodies and therapy in Sjögren's syndrome
15. Randomised double blind comparison of chimeric monoclonal antibody to tumor necrosis factor α versus placebo in rheumatoid arthritis
16. Infliximab and methotrexate in the treatment of rheumatoid arthritis
17. Preliminary criteria for the classification of Sjögren's syndrome: Results of a prospective concerted action supported by the European Community
18. Sjögren's syndrome: Proposed criteria for classification
19. Methods for collecting saliva
20. Labial salivary gland biopsy in Sjögren's disease